Steven Chan

Steven Chan

Directeur Financier/CFO chez
Suzhou Connect Biopharma Co. Ltd.

Fortune : 24 900 $ au 31/05/2026

54 ans
Health Technology
Consumer Durables
Electronic Technology

Profil

Steven Chan currently works at Suzhou Connect Biopharma Co. Ltd., as Chief Financial Officer.
Mr. Chan also formerly worked at Polycom, Inc., as Director-Worldwide Revenue from 2006 to 2007, Logitech International SA, as Controller from 2002 to 2006, MyoKardia, Inc., as Chief Accounting Officer, VP & Controller from 2016 to 2017, Delphon Industries LLC, as Chief Financial Officer from 2019 to 2021, Moody's Analytics, Inc., as Vice President-Finance from 2007 to 2010, Solta Medical, Inc., as Vice President & Controller from 2010 to 2014, Arcus Biosciences, Inc., as Principal Accounting Officer & Controller from 2017 to 2019, and Connect Biopharma Holdings Ltd., as Chief Financial Officer from 2021 to 2024.
Mr. Chan received his undergraduate degree from Haas School of Business.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/03/2025 10 000 ( 0,02% ) 24 900 $ 31/05/2026

Postes actifs de Steven Chan

SociétésPosteDébut
Directeur Financier/CFO -

Anciens postes connus de Steven Chan

SociétésPosteFin
CONNECT BIOPHARMA HOLDINGS LIMITED Directeur Financier/CFO 13/09/2024
Directeur Financier/CFO 01/11/2021
ARCUS BIOSCIENCES, INC. Comptroller/Controller/Auditor 01/04/2019
MYOKARDIA, INC. Directeur Financier/CFO 01/03/2017
Comptroller/Controller/Auditor 01/07/2014
Voir l'expérience en détail de Steven Chan

Formation de Steven Chan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Consumer Durables

Electronic Technology

Health Technology

Process Industries

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Steven Chan